Suchergebnisse - "Subasic, Christopher N"

PubPharm (8)

1

A PEGylated liposomal formulation of prochlorperazine that limits brain exposure but retains dynamin II activity : A potential adjuvant therapy for cancer patients receiving chemotherapeutic mAbs

enthalten in: Nanomedicine : nanotechnology, biology, and medicine | 2024

von Subasic, C. | Simpson, F. | Minchin, R. | +1

2

Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms

enthalten in: Expert opinion on drug delivery | 2024

von Kaminskas, L. | Butcher, N. | Subasic, C. | +8

3

Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats

enthalten in: Molecular pharmaceutics | 2023

von Subasic, C. | Butcher, N. | Simpson, F. | +2

4

Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats

enthalten in: Molecular pharmaceutics | 2023

von Subasic, C. | Butcher, N. | Minchin, R. | +1

5

Utilization of endogenous albumin trafficking pathways in the lungs has potential to modestly increase the lung interstitial access and absorption of drug delivery systems after inhaled administration

enthalten in: Expert opinion on drug delivery | 2023

von Ibrahim, J. | Butcher, N. | Kothapalli, A. | +5

6

Development of a hyperbranched polymer-based methotrexate nanomedicine for rheumatoid arthritis

enthalten in: Acta biomaterialia | 2022

von Marasini, N. | Er, G. | Fu, C. | +6

7

Poly(HPMA-co-NIPAM) copolymer as an alternative to polyethylene glycol-based pharmacokinetic modulation of therapeutic proteins

enthalten in: International journal of pharmaceutics | 2021

von Subasic, C. | Ardana, A. | Chan, L. | +7

8

The pharmacokinetics of PEGylated liposomal doxorubicin are not significantly affected by sex in rats or humans, but may be affected by immune dysfunction

enthalten in: Journal of controlled release : official journal of the Controlled Release Society | 2021

von Subasic, C. | Kuilamu, E. | Cowin, G. | +2

1
[1]